The market for reconstructive breast surgery is growing due to rising incidence and prevalence rates for breast cancer and greater public awareness of the procedure. The rise in breast cancer cases and benevolent reimbursement policies likely contribute to the growth. Additionally, market growth is anticipated to be fueled by technological developments and increased breast reconstruction procedures.
According to Data Bridge Market Research, the Breast Reconstruction was USD 567 million in 2021, would rocket up to USD 917.44 million by 2029, and is expected to undergo a CAGR of 6.2% during the forecast period of 2022-2029.
"Increasing numbers of people being diagnosed with breast cancer boost market expansion.”
Worldwide, the number of breast cancer patients has increased. The WHO anticipates 2.3 million women will be diagnosed with breast cancer worldwide by 2020. A similar source also claims that 7.8 million new breast cancer cases will be analyzed between 2015 and 2020. According to Cancer Research U.K, approximately 55,900 new cases of breast cancer are discovered each year in the U.K. alone. A similar source claims that breast cancer is also the most common type in the United Kingdom. As more women are being diagnosed with breast cancer, there will likely be a rise in the demand for breast reconstruction, which will propel market growth over the forecast period. Similar to the United States, one in seven women in the United Kingdom will receive a breast cancer diagnosis, according to Breast Cancer Now. The market will expand as a result of the more significant number of people who are in need.
What restraints the growth of the Europe Breast Reconstruction Market?
“High cost of surgical expenses will limit the market growth rate."
High surgical costs and difficulties, such as unfavorable surgical outcomes, changes in nipple and breast sensation, the formation of scars, and, in some cases, rupture with deflation of saline-filled implants related to breast reconstructions, have slowed the growth of the breast reconstruction market. These issues are related to acellular dermal matrices (ADMs), as hematoma, skin necrosis, and seroma are the most frequently reported complications following ADM breast reconstruction procedures.
Segmentation: Europe Breast Reconstruction Market
The Europe breast reconstruction market is segmented on the basis of technology, type, reconstruction shape, placement, end-user and distribution channel.
- On the basis of Technology, the breast reconstruction market is segmented into Inframammary, Peri-Areolar, Trans-Axillary, Transumbilical.
- On the basis of Type, the breast reconstruction market is segmented into Alloplastic, Autologous.
- On the basis of Reconstruction Shape, the breast reconstruction market is segmented into Round Implant Shape, Anatomical Implant Shape, Round Expander Shape, Anatomical Expander Shape.
- On the basis of Placement, the breast reconstruction market is segmented into Dual-Plane Insertion, Sub-Glandular Insertion, Sub-Muscular Insertion.
- On the basis of End-User, the breast reconstruction market is segmented into Hospitals, Clinics, Ambulatory Surgical Centers.
- On the basis of Distribution Channel, the breast reconstruction market is segmented into Direct Tenders, Retail.
Regional Insights: Russia is expected to dominate the Europe Breast Reconstruction Market
Russia dominates the market and will continue to flourish its trend of dominance during the forecast period. The major factors attributable to the region’s dominance are the rising incidence and prevalence of breast cancer in the nation and the increased use of multifunctional modifiers in skin care and personal care products, which has fueled market growth; Russia currently holds a dominant position in the industry.
To know more about the study, visit, https://www.databridgemarketresearch.com/jp/reports/europe-breast-reconstruction-market
Recent Developments in Europe Breast Reconstruction Market
- In 2022, The U.S. Food and Drug Administration approved a new MENTOR Memory Gel enhance breast implant from Mentor Worldwide LLC (Johnson and Johnson).
- The FDA approved POLYTECH Health and Aesthetics' textured breast implants in 2021. (implants with macrotexture and polyurethane coating).
- In 2020, U.S. Food and Drug Administration granted Sientra pre-market approval for its OPUS-branded breast implant products.
The Prominent Key Players Operating in the Breast Reconstruction Market Include:
- POLYTECH Health and Aesthetics GmbH (Germany)
- CEREPLAS (France)
- Guangzhou Wanhe Plastic Material Co., Ltd (China)
- ALLERGAN (Ireland)
- Johnson & Johnson Private Limited (U.S)
- GC Aesthetics (U.K)
- Laboratories Arion (France)
- Sientra Inc. (California)
- HANSBIOMED CO. LTD (South Korea)
- Sientra, Inc. (U.S)
- Deal Implant Incorporated (U.S)
- Integra LifeSciences (U.S)
- PMT Corporation (U.S)
- RTI Surgical (U.S)
- Establishment Labs S.A. (U.S)
- Silimed (Brazil)
Above are the key players covered in the report, to know about more and exhaustive list of breast reconstruction market companies contact, https://www.databridgemarketresearch.com/jp/contact
Research Methodology: Europe Breast Reconstruction Market
Data collection and base year analysis are done using data collection modules with large sample sizes. The market data is analyzed and estimated using market statistical and coherent models. In addition, market share analysis and key trend analysis are the major success factors in the market report. The key research methodology used by dbmr research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include vendor positioning grid, market time line analysis, market overview and guide, company positioning grid, company market share analysis, standards of measurement, global vs regional and vendor share analysis. Please request analyst call in case of further inquiry.
